Correlation Between Australian Strategic and PYC Therapeutics

Can any of the company-specific risk be diversified away by investing in both Australian Strategic and PYC Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Australian Strategic and PYC Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Australian Strategic Materials and PYC Therapeutics, you can compare the effects of market volatilities on Australian Strategic and PYC Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Australian Strategic with a short position of PYC Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Australian Strategic and PYC Therapeutics.

Diversification Opportunities for Australian Strategic and PYC Therapeutics

0.43

Correlation Coefficient

Australian Strategic  PYC Therapeutics

Very weak diversification

The 3 months correlation between Australian and PYC is 0.43. Overlapping area represents the amount of risk that can be diversified away by holding Australian Strategic Materials and PYC Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on PYC Therapeutics and Australian Strategic is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Australian Strategic Materials are associated (or correlated) with PYC Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of PYC Therapeutics has no effect on the direction of Australian Strategic i.e., Australian Strategic and PYC Therapeutics go up and down completely randomly.

Pair Corralation between Australian Strategic and PYC Therapeutics

Assuming the 90 days trading horizon Australian Strategic Materials is expected to generate 0.9 times more return on investment than PYC Therapeutics. However, Australian Strategic Materials is 1.12 times less risky than PYC Therapeutics. It trades about 0.09 of its potential returns per unit of risk. PYC Therapeutics is currently generating about -0.48 per unit of risk. If you would invest  49.00  in Australian Strategic Materials on October 24, 2024 and sell it today you would earn a total of  2.00  from holding Australian Strategic Materials or generate 4.08% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Australian Strategic Materials  vs.  PYC Therapeutics

Australian Strategic

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Australian Strategic Materials has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest uncertain performance, the Stock's primary indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.

PYC Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days PYC Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's fundamental indicators remain comparatively stable which may send shares a bit higher in February 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Pair Trading with Australian Strategic and PYC Therapeutics

The main advantage of trading using opposite Australian Strategic and PYC Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Australian Strategic position performs unexpectedly, PYC Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in PYC Therapeutics will offset losses from the drop in PYC Therapeutics' long position.

The idea behind Australian Strategic Materials and PYC Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.